All results
2 results for traditional versus early aggressive therapy multiple sclerosis treatms trial
-
Clinical Trials
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has…
-
News, Stories & Blog
2017 was a tremendous year of continued growth and progress for UF Health. In this “year-in-review” issue of OTSP, we highlight achievements in each of the…